MetaCap

Disc Medicine Earnings

NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD

62.06+1.29 (+2.12%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$-1.65

Disc Medicine earnings summary

Disc Medicine is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-1.65. In its most recent report on Jul 30, 2026 (Q2 2026), IRON posted EPS of $-1.54. Across the last 16 reports, IRON shares moved an average of 5.0% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.

Summary generated from market data by MetaCap's automated system. Methodology

IRON earnings history

Disc Medicine reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 30, 2026—$-1.54—+0.6%
May 5, 2026—$-1.65—-2.1%
Feb 26, 2026—$-1.64—-8.2%
Nov 6, 2025—$-1.77—+7.3%
Aug 7, 2025—$-1.58—+3.2%
May 7, 2025—$-1.02—+8.7%
Feb 27, 2025—$-0.95—-0.9%
Nov 12, 2024—$-0.89—+9.2%
Aug 8, 2024—$-1.03—+11.3%
May 9, 2024—$-1.09—+6.0%
Mar 21, 2024—$-0.90—+2.7%
Nov 9, 2023—$-0.58—+6.9%
Aug 11, 2023—$-0.74—-2.1%
May 15, 2023—$-1.20—-3.8%
Mar 31, 2023—$-7.42—+6.2%
Nov 10, 2022—$-16.82—+1.2%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related